<Abstract of published report>The Interaction of Botrocetin with Normal or Variant von Willebrand Factor (Types IIA and IIB) and Its Inhibition by Monoclonal Antibodies that Block Receptor Binding.

スポンサーリンク

概要

• 論文の詳細を見る
• 岐阜薬科大学の論文
• 1993-06-30

著者

• Titani K.

  Institute Of Comprehensive Medical Science Fujita Health University

• FUJIMURA Y.

  Blood Transfusion Medicine, Nara Medical University

• Yoshioka A.

  Departments Of Pediatrics Nara Medical University

• Fujimura Y.

  Blood Transfusion Medicine Nara Medical University

関連論文

• Upshaw-Schulman Syndrome Revisited: A Concept of Congenital Thrombotic Thrombocytopenic Purpura
• The Interaction of Botrocetin with Normal or Variant von Willebrand Factor (Types IIA and IIB) and Its Inhibition by Monoclonal Antibodies that Block Receptor Binding.
• Isolation and chemical characterization of two structurally and functionally distinct forms of botrocetin, the platelet coagglutinin isolated from the venom of Bothrops jararaca.
• Studies on anti-von Willebrand factor (vWF) monoclonal antibody NMC-4,which inhibits both restocetin- and botrocetin-induced vWF binding to platelet glycoprotein Ib.

スポンサーリンク